Skip to main content

Kookmin Bio

Jeonju, South Korea

Kookmin Bio is a biotechnology company that specialises in the development of bio-food and pharmaceutical materials.

$2.4M raised
Nov 2024
Series B

Top Investors

New Paradigm InvestmentIndustrial Bank of KoreaK Ground VenturesKorea Alternative Investment Asset ManagementKMU Holdings

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Kookmin Bio

How much funding has Kookmin Bio raised?
Kookmin Bio has raised $2.4M in total funding. The most recent round was Series B. The last funding was announced in November 2024.
Who are Kookmin Bio's investors?
Kookmin Bio's investors include New Paradigm Investment, Industrial Bank of Korea, K Ground Ventures, Korea Alternative Investment Asset Management, KMU Holdings.
Where is Kookmin Bio headquartered?
Kookmin Bio is headquartered in Jeonju, South Korea.
What does Kookmin Bio do?
Kookmin Bio is a biotechnology company that specialises in the development of bio-food and pharmaceutical materials.
What stage is Kookmin Bio at?
Kookmin Bio is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Kookmin Bio — Funding & Investors." VCBacked, November 20, 2024, https://www.vcbacked.co/company/kookmin-bio. Accessed June 10, 2026.
APA
VCBacked. (2024). Kookmin Bio — Funding & Investors. Retrieved June 10, 2026, from https://www.vcbacked.co/company/kookmin-bio
Wikipedia (cite web)
{{cite web |title=Kookmin Bio — Funding & Investors |url=https://www.vcbacked.co/company/kookmin-bio |website=VCBacked |access-date=June 10, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .